Finance

Beta
Lists
CNC:NYSE
Centene Corp
$62.33
-0.59%
(-0.37) 1D
$62.33
0.00% (0.00)
After hours
Closed: Jun 5, 4:01:48 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNC...
Open
$62.64
High
$62.96
Low
$61.70
Mkt. cap
30.78B
Avg. vol.
6.47M
Volume
3.96M
52-wk high
$63.50
52-wk low
$25.08
EPS
-$13.14
Beta
1.09
Shares outstanding
493.80M
No. of employees
61K
Open
$62.64
High
$62.96
Low
$61.70
Mkt. cap
30.78B
Avg. vol.
6.47M
Volume
3.96M
52-wk high
$63.50
52-wk low
$25.08
EPS
-$13.14
Beta
1.09
Shares outstanding
493.80M
No. of employees
61K
Analyst outlook
Analyst Ratings
Based on 17 analysts giving stock ratings to CNC in the past 3 months
Buy
Buy
7
Hold
9
Sell
1
12 month forecast
Based on 17 Wall Street analysts offering 12 month price targets for CNC in the last 3 months.
Highest
Current $62.33
$80.00 (+28.35%)
Average
$58.88 (-5.54%)
Lowest
$39.00 (-37.43%)
News stories
From sources across the web
Profile
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500. Wikipedia
About Centene Corp
CEOSarah M. London
Employees61.1K
Founded1984
HeadquartersSt. Louis, Missouri, United States
SectorHealth care provider
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$3.37 / $2.13
+57.91%beat
Revenue / Est. (USD)
45.06B / 47.55B
-5.23%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
42.46B
45.35B
45.09B
45.06B
Cost of goods sold
38.81B
40.90B
41.49B
38.30B
Cost of revenue
38.81B
40.90B
41.49B
38.30B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.04B
3.14B
3.35B
3.38B
Operating expense
4.06B
4.20B
4.45B
4.48B
Total operating expenses
42.87B
45.10B
45.94B
42.78B
Operating income
-412.00M
248.00M
-847.00M
2.28B
Other non operating income
371.00M
-
-
-
EBT including unusual items
-257.00M
-6.67B
-1.54B
2.10B
EBT excluding unusual items
-211.00M
78.00M
-1.02B
2.12B
Income tax expense
2.00M
-42.00M
-443.00M
560.00M
Effective tax rate
-0.78%
0.63%
28.71%
26.68%
Other operating expenses
712.00M
745.00M
771.00M
794.00M
Net income
-253.00M
-6.63B
-1.10B
1.54B
Net profit margin
-0.60%
-14.62%
-2.44%
3.42%
Earnings per share
-0.16
0.50
-1.19
3.37
Interest and investment income
-
-
-
-
Interest expense
-170.00M
-170.00M
-168.00M
-164.00M
Net interest expenses
-170.00M
-170.00M
-168.00M
-164.00M
Depreciation and amortization charges
141.00M
147.00M
160.00M
134.00M
EBITDA
-97.00M
565.00M
-518.00M
2.58B
Gain or loss from assets sale
-
-
501.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more